Rhenman & Partners Asset Management AB

Holdings History for AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO)

Symbol: AGIO on Nasdaq
Investment type: Equity / Common stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2021		-0.46%	$0	0	-130,000	-100%	$28.32	Q1 2021
31 Dec 2020	0.46%	+0.14%	$5,633,000	130,000	+40,000	+44%	$43.33	Q4 2020
30 Sep 2020	0.28%	0%	$3,150,000	90,000	0		$35.00	Q3 2020
30 Jun 2020	0.52%	-0.12%	$4,813,000	90,000	-20,000	-18%	$53.48	Q2 2020
31 Mar 2020	0.55%	-0.25%	$3,903,000	110,000	-50,000	-31%	$35.48	Q1 2020
31 Dec 2019	0.84%	-0.44%	$7,640,000	160,000	-85,002	-35%	$47.75	Q4 2019
30 Sep 2019	1%	+0.18%	$7,938,000	245,002	+45,002	+23%	$32.40	Q3 2019
30 Jun 2019	1.1%	+0.41%	$9,976,000	200,000	+72,988	+57%	$49.88	Q2 2019
31 Mar 2019	1%	0%	$8,566,000	127,012	0		$67.44	Q1 2019
31 Dec 2018	0.67%	-0.1%	$5,857,000	127,012	-18,416	-13%	$46.11	Q4 2018
30 Sep 2018	1.1%	-0.12%	$11,215,000	145,428	-15,000	-9.3%	$77.12	Q3 2018
30 Jun 2018	1.4%	+0.56%	$13,513,000	160,428	+65,428	+69%	$84.23	Q2 2018
31 Mar 2018	0.96%	-0.05%	$7,769,000	95,000	-5,000	-5%	$81.78	Q1 2018
31 Dec 2017	0.77%	+0.66%	$5,717,000	100,000	+85,000	+567%	$57.17	Q4 2017
30 Sep 2017	0.13%	+0.13%	$1,001,000	15,000	+15,000	NEW	$66.73	Q3 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.